Predict your next investment

Corporation
HEALTHCARE | Drug Manufacturing
humanwell.com.cn

See what CB Insights has to offer

Founded Year

1993

Stage

IPO | IPO

Date of IPO

6/6/1997

Market Cap

45.50B

About Humanwell Healthcare Group

Humanwell Healthcare Group (600079.SH) is a fully integrated healthcare solutions provider. The company engages in manufacturing, sales, marketing, and distribution of anesthetics and analgesics, women's health products, CNS drugs, herbal medicines, anti-infection drugs, OTC medicines, and other products.

Humanwell Healthcare Group Headquarter Location

No.666 Gaoxin Road East Lake High-tech Development Zone

Wuhan, Hubei, 430075,

China

+86 027-87597232

Latest Humanwell Healthcare Group News

Owners of Condom Maker Lifestyles Mull $500 Million Sale

Jul 23, 2021

Jul 23 2021, 2:19 PM July 23 2021, 1:29 PM July 23 2021, 2:19 PM (Bloomberg) -- The owners of Lifestyles Healthcare are weighing a sale of the condom and lubricants maker’s operations outside of China for about $500 million, according to people familiar with the matter. (Bloomberg) -- The owners of Lifestyles Healthcare are weighing a sale of the condom and lubricants maker’s operations outside of China for about $500 million, according to people familiar with the matter. Citic Capital, which owns a 40% stake in Lifestyles Healthcare, has asked on behalf of a group of shareholders for pitches for the potential disposal, said the people, who asked not to be identified as the discussions are private. The owners, which also include private equity firms Hillhouse Capital and Boyu Capital, intend to keep the condom maker’s business in China after the divestment, the people said. Lifestyles Healthcare’s history dates back to 1905 when its founder Eric Ansell first started making condoms in Australia, according to its website . The company operates manufacturing facilities in China, India and Thailand and its products are available in more than 40 countries. Among its brands is Jissbon, a Chinese translation of fictional British spy James Bond that aims to cash in on the popularity of a secret agent who became almost as famous for his sexual exploits as his missions to save the world. Lifestyles Healthcare also owns brands including its namesake Lifestyles, Manix as well as Blowtex and non-latex condom brand SKYN. Lifestyles Healthcare was created after a consortium of Citic Capital and Humanwell Healthcare Group Co. bought the condom and lubricants business from Sydney-listed Ansell Ltd. for $600 million in 2017. Last year, Hillhouse Capital, Boyu Capital and CareCapital Partners acquired a 40% stake in Lifestyles Healthcare for $200 million, according to an exchange filing by Humanwell at the time. Humanwell still owns a 20% stake in the condom maker. Considerations are preliminary and the owners could decide to keep the business, the people said. A representative for Citic Capital declined to comment, while a representative for Humanwell said the company currently has no plans to sell its stake. Boyu Capital, CareCapital and Hillhouse representatives couldn’t immediately comment. ©2021 Bloomberg L.P.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Humanwell Healthcare Group Patents

Humanwell Healthcare Group has filed 8 patents.

The 3 most popular patent topics include:

  • Experimental cancer drugs
  • Antineoplastic drugs
  • Fluoroarenes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/22/2019

3/9/2021

Experimental cancer drugs, Antineoplastic drugs, Radiation therapy, Fluoroarenes, Lactams

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/22/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/9/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Experimental cancer drugs, Antineoplastic drugs, Radiation therapy, Fluoroarenes, Lactams

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Humanwell Healthcare Group Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Humanwell Healthcare Group Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.